Bystanders or Bad Seeds? Many Autoimmune-target Cells May Be Transforming to Cancer and Signalling “Danger” to the Immune System

References

• Kuhn T. S. The Structure of Scientific Revolutions. University of Chicago Press, Chicago 1962
   Google Scholar
• Reines B. On the locus of medical discovery. J Med Phil 1991; 16: 183–201
   PubMedGoogle Scholar
• Rubin H. Incipient and overt stages of neoplastic transformation. Proc. Natl. Acad. Sci (USA) 1994; 91: 12076–12080
   PubMedGoogle Scholar
• Matzinger P. Tolerance, danger and the extended family. Annu Rev Immunol 1994; 12: 991–1045
   PubMed Web of Science ®Google Scholar
• Lynch H., Albano W., Rccerbaren J., et al. Prolonged survival as a component of hereditary breast and nonpolyposis colon cancer. Med Hypotheses 1981; 7: 1201–1209
   PubMedGoogle Scholar
• Wilkin T. J. The primary lesion theory of autoimmunity: A speculative hypothesis. Autoimmunity 1990; 7: 225–235
   PubMed Web of Science ®Google Scholar
• Drexhage H., Delemarre F., Radosevic K., Leenen P. Dendritic cells in autoimmunity. Dendritic Cells: Biology and Clinical Applications, M. Lotze, A. Thomson. Academic Press, San Diego 1999; 361–380
   Google Scholar
• Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619
   PubMed Web of Science ®Google Scholar
• Muller-Ladner U., Kriegsmann J., Franklin B. N., et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996; 149: 1607–1615
   PubMed Web of Science ®Google Scholar
• Young N. The problem of clonality in aplastic anemia: Dr. Dameshek's riddle, restated. Blood 1992; 79(6)1385–1392
   PubMedGoogle Scholar
• Muller-Ladner U, Kriegsmann J, Gay R, Gay S. Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Amer 1995; 21(3)675–689
   PubMedGoogle Scholar
• Narayanan M., Geary C, Freemont A, Kendra J. Long-term follow-up of aplastic anemia. Brit J Hematol 1994; 86: 837–843
   PubMed Web of Science ®Google Scholar
• Pardoll D. Introduction: Cancer and the immune system. Semin Immunol 1996; 8: 269–270
   Google Scholar
• Bridges B. UV-induced mutations and skin cancer: how important is the link?. Mutat Res 1998; 422(1)23
   PubMedGoogle Scholar
• Silverstein A., Rose N. On the mystique of the immunological self. Immunol Rev 1997; 159: 197–206
   PubMedGoogle Scholar
• Rubin H. Cellular aging, destabilization, and cancer. Proc Natl Acad Sci (USA) 1996; 93: 1825–1830
   PubMed Web of Science ®Google Scholar
• Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nature Med 1999; 5(11)1249–55
   PubMed Web of Science ®Google Scholar
• Wilkin T. J. Autoimmune diabetes and the germ theory of disease. Diabetologia 1992; 35: 187–189
   PubMedGoogle Scholar
• Fuchs E, Matzinger P. Is cancer dangerous to the immune system?. Semin Immunol 1996; 8: 271–280
   PubMedGoogle Scholar
• Casciola-Rosen L., Rosen A., Petri M., Schlisscl M. Surface blebs on apoptotic cells are sites of enhanced pro-coagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc. Nati.Acad. Sci. USA 1996; 93(4)1624–1629
   PubMedGoogle Scholar
• Kuhn H., Kromminga A., Flammann H. T., Frey M., Layer P., Arndt R. p53 autoantibodies in patients with autoimmune diseases: a quantitative approach. Autoimmunity 1999; 31: 229–235
   PubMed Web of Science ®Google Scholar
• Grabar P. Hypothesis: Auto-antibodies and immunological theories: an analytical review. Clin Immunol Immunoputh 1975; 4: 453–466
   PubMedGoogle Scholar
• Bell D., Varley J., Szydlo T., Rang D., Wahrer D., Shannon K., et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 1999; 286(5449)2528–2531
   PubMedGoogle Scholar
• Houlston RS and Stratton MR Genetics of non-medullary thyroid cancer. Quart. J. Med. 1995; 88(10)685–93
   Google Scholar
• Spitale L, Jimenez D, Gramatica L. Latent carcinoma of the thyroid in surgical samples. Rev Fuc Ciert Med Univ Nac Cordoba 1997; 55(1–2)15–20
   PubMedGoogle Scholar
• Peller S. Cancer Research Since 1900: A Critical Appraisal. New York Philosophical Library, New York 1980
   Google Scholar
• Todd J, Bell J, McDevitt H. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599–604
   PubMed Web of Science ®Google Scholar
• McCurdy D., Tai L., Frias S., Wang Z. Delayed repair of DNA damage by ionizing radiation in cells from patients with juvenile systemic lupus erythematosus and rheumatoid arthritis. Racliat Res 1997; 147: 48–54
   Google Scholar
• Sundick R. Target organ defects in thyroid autoimmune disease. Immunol Res 1989; 8: 39–60
   PubMedGoogle Scholar
• Simons P, Delemarre F, Jeucken P, Drexhage H. Pre-autoimmune thyroid abnormalities in the biobreeding diabetes-prone (BB-DP) rat: a possible relation with the intrathyroid accumulation of dendritic cells and the initiation of the thyroid autoimmune response. J Endocrinol 1998; 157: 43–51
   PubMed Web of Science ®Google Scholar
• Bennet M, Evan G, Schwartz S. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995; 95: 2266–2274
   PubMedGoogle Scholar
• Maciejewski J P, Anderson S, Kalevas P, Young N S. Phe-notypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure. Br J Haematol 1994; 87(2)227–34
   PubMed Web of Science ®Google Scholar
• Morocutti A, Earle K, Sethi M, Piras G, Pal K, Richards D., et al. Premature senescence of skin fibroblasts from insulin-dependent diabetic patients with kidney disease. Kidney Int 1996; 50: 250–256
   PubMedGoogle Scholar
• Jonasson L., Eriksson T., Dahle'n G., Lindblom B. Lipoprotein(a) and HLA-DRBI and -DQB1 genes in coronary artery disease. Atherosclerosis 1997; 133(1)111–114
   PubMedGoogle Scholar
• Parkes J, Cardell R, Hubbard F., Hubbard D, Meltzer A, Penn A. Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene. Am J Pathol 1991; 138: 765–775
   PubMedGoogle Scholar
• Nissen C. The pathophysiology of aplastic anemia. Sent Hematol 1991; 28(4)313–318
   Google Scholar
• Rubin H., Yao A., Chow M. Neoplastic development: paradoxical relation between impaired cell growth at low population density and excessive growth at high density. Proc. Natl. Acad. Sci. (USA) 1995; 92: 7734–7738
   PubMedGoogle Scholar
• Stern R, Milestone B, Gatenby R. Carcinogenesis and the plasma membrane. Med Hypotheses 1999; 52(5)367–372
   PubMedGoogle Scholar
• Trevisan R, Li L, Messent J, Tariq T, Earle K, Walker J, Viberti G. Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 1992; 41: 1239–1246
   PubMed Web of Science ®Google Scholar
• Trosko J. E. Hierarchical and cybernetic nature of biologic systems and their relevance to homeostatic adaptation to low-level exposures to oxidative stress-inducing agents. Environ Health Perspect 1998; 106: 331–339
   PubMed Web of Science ®Google Scholar
• Toussaint O., Fuchs S., Ronai Z., Isoyama S., Yuko N., Petronilli V., et al. Recipricoal relationships between the resistance to stresses and cellular aging. Ann N Y Acad Sci 1998; 851: 451–465
   Google Scholar
• Michel P., Eggcrt W., Albrecht-Nebe H., Grune T. Increased lipid peroxidation in children with autoimmune diseases. Acta Paediatr 1997; 86(6)609–612
   PubMedGoogle Scholar
• Notaro R, Montuori N, Di Grazia C, et al. Fanconi's anemia cells are relatively resistant to H202-induced damage. Haemutoiogica 1998; 83: 868–874
   PubMedGoogle Scholar
• Poli G, Cecchini G, Biasi F., et al. Resistance to oxidative stress by hyperplastic and neoplastic rat liver tissue monitored in terms of production of unpolar and medium polar carbonyls. Biochimica et Biophysica Acta 1986; 883: 207–214
   PubMedGoogle Scholar
• Reines B. Xeroderma pigmentosum as a model of lumor-resistance. The Lynch paradox revisited 2000, In preparation for Cancer Immunol Immunother.
   Google Scholar
• Watson P, Lin K, Rodriguez-Bigas M, Smyrk T, Lemon S, Shashidharan M, Franklin B., et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer 1998; 83(2)259–266
   PubMed Web of Science ®Google Scholar
• Tomoda H, Baba H, Akazawa K. Prolonged survival in hereditary nonpolyposis colorectal cancer. Oncol Rep 1999; 6(2)321–4
   PubMedGoogle Scholar
• Graham D, Appelman H. Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prog-nosticator. Mod Pathol 1990; 3: 332–335
   PubMed Web of Science ®Google Scholar
• Lynch H., Frichot B., Fisher J., et al. Spontaneous regression of metastatic malignant melanoma in 2 sibs with xeroderma pigmentosum. J Med Genet 1978; 15(5)357–362
   PubMedGoogle Scholar
• Anstey A, Arlett C, Cole J, Norris P., Hamblin A, Limb G, Lehrnann A, Wilkinson J, Turner M. Long-term survival and preservation of natural killer cell activity in a xeroderma pigmentosum patient with spontaneous regression and multiple deposits of malignant melanoma. Brit J Dermatol 1991; 125: 272
   PubMedGoogle Scholar
• Kocabalkan O, Ozgur F., Erk Y, Gursu K, Gungen Y. Malignant melanoma in xeroderma pigmentosum patients: report of five cases. Eur J Surg Oncol 1997; 23: 43
   PubMedGoogle Scholar
• DiGiovanni J, Patronas N, Katz D, Abangan D, Kraemer K. Xeroderma pigmentosum: spinal cord astrocytoma with 9-year survival after radiation and Isotretinoin therapy. J Cut Med Surg 1998; 2(3)153
   PubMedGoogle Scholar
• Kraemer K., Lee M., Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 1987; 5: 511
   Google Scholar
• Reardon J, Bessho T, Kung H, Bolton P, Sancar A. In vitro repair of oxidative DNA damage by human nucleotide excision repair system: Possible explanation for neurode-generation in Xeroderma pigmentosum patients. Proc. Natl. Acad. Sci. USA 1997; 94: 9463
   PubMed Web of Science ®Google Scholar
• Johnson R. T., Squires S. The XPD complementation group: Insights into xeroderma pigmentosum, Cockayne's syndrome and trichothiodystrophy. Mutat Res 1992; 273: 97
   PubMedGoogle Scholar
• Giglia G, Dumaz N, Drougard C, Avril M, Daya-Grosjean L, Sarasin A. p53 Mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Cancer Re.s 1998; 58: 4402
   PubMedGoogle Scholar
• Kuwamato K, Miyauchi-Hashimoto H, Isei T, Horio T. Xeroderma pigmentosum variant associated with multiple cancers. Photodermatol Photoimmunol Photomed 1999; 15: 327
   Google Scholar
• Heintz N. Cell death and the cell cycle: a relationship het-Ien transformation and neurodegcneration?. Trends Bio-chemSci 1993; 18: 156–159
   Google Scholar
• Kuljis R., Aguila M. Neurodegcneration in ataxia-telangiectasia is caused by horror autotoxicus. Med Hypotheses 1999; 52(5)377
   PubMedGoogle Scholar
• Hickey W., Ucno K., Hiserodt J., Schmidt R. Exoge-nously-induced, natural killer cell-mediated neuronal killing: a novel pathogenetic mechanism. J Exp Med, 176(3)811
   PubMedGoogle Scholar
• Klcgeris A., McGeer P. Interaction of various intracellular signalling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells. J Leukoc Biol 2000; 67: 127
   PubMedGoogle Scholar
• Sherer Y., Shoenfeld Y. A malignancy work-up in patients with cancer-associated (paraneoplastic) autoimmune diseases: pemphigus and myasthenic syndromes as cases in point (Review). Oncol Rep 1999; 6: 665–668
   PubMedGoogle Scholar
• Kanda T, Oda M, Yonezawa M, Tamagawa K, Isa F, Hana-Kago R, Tsukagoshi H. Peripheral neuropathy in Xeroderma pigmentosum. Brain 1990; 113: 1025
   PubMedGoogle Scholar
• Magy L, Bassez G., Chassande B, Poynard T, Leger J M. Sensory neuronopathy associated with chronic autoimmune hepatitis. Rev Neurol (Paris) 1997; 155(1)70
   Google Scholar
• Dalmau J., Gultekin H., Posner J. Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Bruin Pathol 1999; 9: 275
   PubMed Web of Science ®Google Scholar
• Darnell R. Onconeural antigens and the paraneoplastic neurologic disorders: the intersection of cancer, immunity and the brain. Proc Natl Acad Sci USA 1996; 93: 4529
   PubMed Web of Science ®Google Scholar
• Hananian J., Cleaver J. Xeroderma pigmentosum exhibiting neurological disorders and systemic lupus erythematosus. Clin. Genet. 1980; 17(1)39
   PubMedGoogle Scholar
• Darnell R, De Angclis R. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 1993; 341: 21
   Google Scholar
• Lever A., Hole D., Gillis C., McCailum I., McInnes G., MacKinnon P., et al. Do inhibitors of angiotensin-1-converting enzyme protect against risk of cancer?. Lancet 1998; 352: 179–184
   PubMed Web of Science ®Google Scholar
• Hughes D., Manns B. Patient compliance with drug therapy for diabetic nephropathy. CMAJ 2000; 162(11)1553
   PubMedGoogle Scholar
• Moss S. E., Klein R., Klein B. Cause-specific mortality in a population-based study of diabetes. Am J Public Health 1991; 81: 1158–1162
   PubMed Web of Science ®Google Scholar
• Syrigos K., Konstantoulakis M., Fyssas I., et al. Autoantibodies against insulin and [3-islet cells in pancreatic adenocarcinoma: A possible explanation for diabetes mellitus. Int J Cancer 1996; 66: 624–626
   PubMed Web of Science ®Google Scholar
• Kocnig W., Sund M., Frohlich M., Fischer H. G., Loll H., Doring A., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99(2)237–242
   PubMedGoogle Scholar
• Badolato R., Oppenheim J. Role of cytokines. acute-phase proteins, and chemokines in the progression of rheumatoid arthritis. Semin Arthritis Rheum 1996; 26(2)526–538
   PubMedGoogle Scholar
• Studnicka-Benke A., Steiner G., Petera P., Smolen J. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br. J Rheumatol 1996; 35(11)1067–1074
   PubMedGoogle Scholar
• Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes 1994; 43: 613–621
   Google Scholar
• Pietropaolo M., Barinas-Mitchell E., Pietropaolo S., Kuller L., Trucco M. Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes. Diabetes 2000; 49: 32–38
   PubMed Web of Science ®Google Scholar
• Pickup J, Crook M. Is type II diabetes a disease of the innate immune system?. Diahetologia 1998; 41: 1241–1248
   PubMed Web of Science ®Google Scholar
• O'Riordain M. G., Falconer J. S., Maingay J., Fearon K. C., Ross J. A. Peripheral blood cells from weight-losing cancer patients control the hepatic acute phase response by a primarily interleukin-6 dependent mechanism. hit J Oncol 1999; 15(4)823–827
   Google Scholar
• Abraha A., Schultz C., Konopelska-Bahu T, James T., Watts A., Stratton I., et al. Glycaemic control and familial factors determine hyperlipidaemia in early childhood diabetes. Oxford Regional Prospective Study of Childhood Diabetes. Diabet Med 1999; 16(7)598–604
   PubMedGoogle Scholar
• Popovic J L., Oreskovic K., Zupancic B., Petrunic M., Kunec-Vajic E. The relation betlen plasma lipid levels and pseudocholinesterase activity in hypothyroidism. Horni Metab Res 1998; 30(3)137–140
   PubMedGoogle Scholar
• Carlson B., Jansson A., Larsson A., Bucht A., Lorentzen J. The endogenous adjuvant squalene can induce a chronic T-cell mediated arthritis in rats. Am J Pathol 2000; 156(6)2057–2065
   PubMedGoogle Scholar
• Lorentzen J., Klarcskog L. Susceptibility of DA rats to arthritis induced with adjuvant oil or rat collagen is determined by genes both within and outside the major histocompatibility complex. Stand J Immunol 1996; 44(6)592–598
   PubMedGoogle Scholar
• Massy Z, Guijarro C, Wiederkehr M., Ma J, Kasiske B. Chronic renal allograft rejection: immunologic and nonim-munologic risk factors. Kidney Int. 1996; 49: 518–524
   PubMed Web of Science ®Google Scholar
• VanderWal A, Piek J, de Boer O, et al. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart 1998; 80(1)14–18
   PubMedGoogle Scholar
• Mergner W., Yu Q., Resau J., Vigorito R., Jacobsen M. The atherosclerotic plaque: tumor or scar?. Etiology of Cancer in Man, A. S. Levine. Kluwer Academic, Dordrecht 1989; 190–206
   Google Scholar
• Malinow M. R., Senner J. W. Arterial pathology in cancer patients suggests atherosclerosis regression. Med Hypotheses 1983; 11(3)353–357
   PubMedGoogle Scholar
• Chernik N, Loelnson R, Posner J, Resch J. Cerebral atherosclerosis and stroke in cancer patients. Neurology 1978; 28: 350
   Google Scholar
• Wanscher O, Clemmesen J, Nielsen A. Negative correlation between atherosclerosis and cancer. Brit J Cancer 1951; 5: 172–174
   PubMed Web of Science ®Google Scholar
• Penn I. See “Cancers in autoimmune diseases” in Cancer as a long-term hazard of immunosuppressive therapy. Immunointervention in Autoimmune Diseases, J. F. Bach. Academic Press, London 1989; 49–62
   Google Scholar
• Cibere J, Sibley J, Haga M. Rheumatoid arthritis and the risk of malignancy. Arthritis Rheum 1997; 40(9)1580–1586
   PubMed Web of Science ®Google Scholar
• Abu-Shakra M, Gladman D. D., Urowilz M. B. Malignancy in systemic lupus erythematosus. Arthritis Rheum. 1996; 39(6)1050–1054
   PubMedGoogle Scholar
• Loh K, Greenspan F, Dong F, Miller T, Yeo P. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma, i. Clin Endocrinol Metab 1999; 84: 458–463
   Google Scholar
• Lake B. Morbid conditions at death in old men. J Cliron Dis 1969; 21: 761–779
   PubMedGoogle Scholar
• Pearce M, Dayton S. Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet 1971; 464–467
   PubMedGoogle Scholar
• Jones P H. Low serum cholesterol increases the risk of non-cardiovascular events: an antagonist viewpoint. Curdiorasc Drugs Ther 1994; 8(6)871–4
   PubMedGoogle Scholar
• MacMahon S. Lowering cholesterol: effects on trauma death, cancer death and total mortality. Aust NZJ Med 1992; 22(5 Suppl)580–2
   PubMedGoogle Scholar
• Durrington P. N. Hyperlipidaemia: Diagnosis and Management. University Press, Cambridge 1995; 93
   Google Scholar
• Jacobs D, Blackburn H, Higgins M., Reed D, Iso H, McMillan G., et al. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992; 86(3)1046–1061
   PubMed Web of Science ®Google Scholar
• Serneri G., Abbate R., Gori A., Attanasio M., Martini F., Giusti B., et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992; 86(3)790–797
   PubMedGoogle Scholar
• Bobryshev Y, Lord R. Mapping of vascular dendritic-cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc Res 1998; 37: 799–810
   PubMedGoogle Scholar
• Van der Wal A, Becker A, Das P. Medial thinning and atherosclerosis-evidence for involvement of a local inflammatory effect. Atherosclerosis 1993; 103(1)55–64
   PubMedGoogle Scholar
• Geng Y, Henderson L, Levesque E., et al. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromh Vase Biol 1997; 17(10)2200–2208
   PubMedGoogle Scholar
• Gu K., Cowie C., Harris M. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993. Diabet. Care 1998; 21(7)1138–1145
   PubMed Web of Science ®Google Scholar
• Katsilambros N., Hatzakis A., Perdicaris G., et al. Total and cause-specific mortality in a population-based cohort of diabetics in Greece. Diabet Metab 1991; 17: 410–414
   Google Scholar
• Kessler I. J. Cancer and diabetes mellitus: a review of the literature. J. Chron Dis 1971; 23: 579–600
   PubMedGoogle Scholar
• Roy S., Lorenzi M. The memory of abnormal gene expression induced by high glucose in human endothelial cells is gene-specific. (Abstract). Diabetes (Suppl I) 1991; 40: 9
   Google Scholar
• Mills J, Knopp R, Simpson J, Jovanovic-Peterson L, et al. Lack of relation of increased malformation rates to infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 1988; 318: 671–667
   PubMed Web of Science ®Google Scholar
• Hu J., Norman M., Wallensteen M., Gennser G. Dynamic properties of the aorta and of the foot microcirculation in adolescents with diabetes mellitus. Acta Paediatr 1997; 86: 620–625
   PubMed Web of Science ®Google Scholar
• Stern M. Diabetes and cardiovascular disease: the common soil hypothesis. Diabetes 1995; 44: 369–374
   PubMed Web of Science ®Google Scholar
• Homo-Delarche F., Boitard C. Autoimmune diabetes: the role of the islets of Langerhans. Immunol Today 1996; 17(10)456–460
   PubMedGoogle Scholar
• Williams R H. Etiologic, pathophysiologic and clinical interrelationships in diabetes. Johns Hopkins Medical Journal 1975; 136: 25–37
   PubMedGoogle Scholar
• Sreenan S., Pick A., Levisetti M., et al. Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes 1999; 48(5)989–996
   PubMedGoogle Scholar
• Kobavashi T. Slowly progressive IDDM. Nippon Rinsho 1999; 57(3)607–611
   Google Scholar
• Ganda O., Soeldner J. Relationship between insulin-secreting islet-cell tumors and diabetes mellitus. Secondary Diabetes: The Spectrum of the Diabetic Syndromes, S. Podolsky, M. Viswanathan. Raven Press, NY 1980; 297–304
   Google Scholar
• Rodriguez-Villar C, Conget I., Casamitjana R., et al. High proinsulin levels in late PRE-IDDM stage. Diabetes Res Clin Pract 1997; 37(2)145–148
   PubMedGoogle Scholar
• Mabsbad S, Harding S., Faber O. C-peptide and proinsulin. International Textbook of Diabetes Mellitus, K. Alberti, R. DeFronzo, H. Keen, P. Zimmet. John Wiley and Sons Ltd., London 1992; 320
   Google Scholar
• Singer-Granick C, Hoffman R., Kerensky K., et al. Glucagon responses to hypoglycemia in children and adolescents with IDDM. Diabetestare 1988; 11: 643–649
   Google Scholar
• Dagogo-Jack S., Craft S., Cryer P. Hypoglyc-emia-associated autonomic failure in insulin-dependent diaetes mellitus: recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J. Clin. Invest. 1993; 91: 819–828
   PubMed Web of Science ®Google Scholar
• Durinovic-Bello I. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens. Autoimmunity 1998; 27: 159–177
   PubMed Web of Science ®Google Scholar
• Roldan M. B., Alonso M., Barrio R. Thyroid autoimmunity in children and adolescents with Type I diabetes mellitus. Diabetes Nutr. Metab. 1999; 12(1)27–31
   PubMedGoogle Scholar
• Hegedus L., Karstrup S., Rasmussen N. Evidence of cyclic alterations of thyroid size during the menstrual cycle in healthy women. J. Obstet. Gynecol. 1986; 155: 142–145
   Google Scholar
• Drexhage H. A. Autoimmunity and thyroid growth. Where do we stand?. Eur J Endocrinol 1996; 135: 39–45
   PubMedGoogle Scholar
• Greenstein A. J. Cancer in inflammatory bowel disease. Ml Sinai J Med. 2000; 67(3)241–4
   PubMedGoogle Scholar
• Hall T. C. Extensive written personal communication to B. Reines. 1995
   Google Scholar
• Skopouli F. N., Dafni U., Ioannidis J. P., Moutsopoulos H. M. Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome. Semin. Arthritis Rheum. 2000; 29(5)296–304
   PubMed Web of Science ®Google Scholar
• Matsiibayashi S, Tamai H, Takaichi Y, Morita T., Matsuzuka F, Suzuki T, Kuma K., Nagataki S. Thyroidal prelymphoma. J Endocrinol Invest. 1988; 11(3)211–4
   PubMedGoogle Scholar
• Naschitz J E, Rosner I, Rozenbaum M, Zuckerman E. Yes-hurun D Rheumatic syndromes: clues to occult neoplasia. Semin Arthritis Rheum. 1999; 29(1)43–55
   PubMedGoogle Scholar
• Sugai S. Malignancy in autoimmune disease. Nihon Rin-sho Meneki Gakkai Kaishi 1996; 19(1)1–14
   PubMedGoogle Scholar
• Dotti G, Fiocchi R, Motta T, Gamba A, Gotti E, Gridelli B, Borleri G, Manzoni C, Viero P, Remuzzi G, Barbui T, Ram-Baldi A. Epstein-Barr virus-negative lymphoproliferative disorders in long-term survivors after heart, kidney and liver transplant. Transplantation 2000; 69(5)827–33
   PubMedGoogle Scholar
• Antonia S., Munoz-Antonia T, Soldevila G., et al. B7–1 expression by a non-antigen presenting cell-derived tumor. Cancer Res 1995; 55: 2253–2256
   PubMed Web of Science ®Google Scholar
• Blackman J., Cabana V., Mazzone T. The acute-phase response and associated lipoprotein abnormalities accompanying lymphoma. J Int Med 1993; 233: 201–204
   PubMed Web of Science ®Google Scholar
• Evoli A, Lo Monaco M, Marra R, Lino M M, Batocchi A P, Tonali P A. Multiple paraneoplastic diseases associated with thymoma. Neuromuscul Disord 1999; 9(8)601–3
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G., Lorber M., Shoenfeld Y. Systemic lupus erythematosus and thymoma-a double-edged sword. Int Arch Allergy Immunol, 108(1)99–102
   PubMedGoogle Scholar
• Hall T C. Oncocognitive autoimmunity and other paraneoplastic syndromes yet to be described. Ann N Y Acad Sci. 1974; 230: 565–70
   PubMedGoogle Scholar
• Todd I, Pujol-Borrell R, Belfiore A, Botazzo G. Thyrocyte class II expression and regulation in relation to thyroid autoimmunity. Acta Endocrinol (Copenh) (Suppl 281) 1987; 115: 27–35
   PubMedGoogle Scholar
• Pelletier J R, Faure M P, DiBattista J A, Wilhelm S, Visco D, Martel-Pelletier J. Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis. An immunohistochemical study. Am J Pathol. 1993; 142(1)95–105
   PubMedGoogle Scholar
• Muller-Ladner U, Kriegsmann J, Gay R, Gay S. Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Amer. 1995; 21(3)675–689
   PubMedGoogle Scholar
• Prasad A, Mohan N, Chandrasekar B, Meltz M. Induction of transcription of immediate early genes' by low-dose ionizing radiation. Rad. Res. 1995; 143: 263–272
   PubMed Web of Science ®Google Scholar
• Cabrera T., Ruiz-Cabello F., Garrido F. Biological implications of HLA-DR expression in tumours. Scand J Immunol 1995; 41(4)398–406
   PubMedGoogle Scholar
• Lu Y., Tschichardt M., Schmidt B., Blanck G. IFN-γ inducibility of class II transactivator is specifically lacking in human tumor lines: relevance to retinoblastoma protein rescue of IFN-y inducibility of the HLA class II genes. Immunol Cell Biol 1997; 75: 325–332
   PubMedGoogle Scholar
• Boman H. Peptide antibiotics: holy or heretic grails of innate immunity. Scand J Immunol 1996; 43: 475–482
   PubMedGoogle Scholar
• Ikemoto S., Sugimura K., Yoshida N., Wada S., Yamamoto K., Kishimoto T. TNF alpha. IL-1 beta and IL-6 production by peripheral blood monocytes in patients with renal cell carcinoma. Anticancer Res 2000; 20(1 A)317–321
   PubMedGoogle Scholar
• Falconer J., Fearon K., Plester C., Ross J., Carter D. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 1994; 219(4)325–341
   PubMed Web of Science ®Google Scholar
• Lmai H, Nakano Y, Kiyosawa K, Tan E. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer 1993; 71: 26–35
   PubMedGoogle Scholar
• Reines B. P. Ontogeny of hemopoiesis. Schalm's Veterinary Hematology, 5 Edition, B. Feldman. Lippincott Williams and Wilkins, Baltimore 2000
   Google Scholar
• Lee Y T. Better prognosis of many cancers in female: a phenomenon not explained by study of steroid receptors. J Surg Oncol 1984; 25(4)255–262
   PubMedGoogle Scholar
• Shaw H. M., Thomson J. F. Superior survival of young women with malignant melanoma. Am J Surg 1999; 178(4)358
   PubMedGoogle Scholar
• McCulloch Taggart P., Ochiai T. A., O'Dowd G., Nash J, Sasako M. C-erbB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan. Eur J Surg Oncol 1997; 23: 304–309
   PubMedGoogle Scholar
• National Cancer Institute. Death rates from 50 countries. Cancer Risks and Rates. 1992, An online publication athttp://rex.nci.nih.gov/NCI_Puh_Interface/rater-isk/index.html
   Google Scholar